{"url":"https://lda.senate.gov/api/v1/filings/2b855ee6-a956-410e-a89a-0c51b217a6a0/","filing_uuid":"2b855ee6-a956-410e-a89a-0c51b217a6a0","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2b855ee6-a956-410e-a89a-0c51b217a6a0/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"BRIAN ABELA","dt_posted":"2026-07-15T11:52:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 N. Market Square, Suite 800","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Harrisburg","registrant_state":"PA","registrant_zip":"17101","registrant":{"id":296293,"url":"https://lda.senate.gov/api/v1/registrants/296293/","house_registrant_id":37505,"name":"BRAVO GROUP","description":"Public Affairs","address_1":"20 N. Market Square, Suite 800","address_2":null,"address_3":null,"address_4":null,"city":"Harrisburg","state":"PA","state_display":"Pennsylvania","zip":"17101","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRIAN ABELA","contact_telephone":"+1 717-214-2200","dt_updated":"2026-07-28T14:48:16.403897-04:00"},"client":{"id":179441,"url":"https://lda.senate.gov/api/v1/clients/179441/","client_id":51,"name":"PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA","general_description":"Advocacy","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-05-18"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13791,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"BRAVACOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140453,"prefix":null,"prefix_display":null,"first_name":"CHRIS","nickname":null,"middle_name":null,"last_name":"GETMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146902,"prefix":null,"prefix_display":null,"first_name":"BRANDON","nickname":null,"middle_name":null,"last_name":"FERRANCE","suffix":null,"suffix_display":null},"covered_position":"Congressional Intern, Staff Assistant, Press Assistant","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}